Japan Hormones Sales is set to reach $2,820 Million by 2026 from $2,470 Million 2021, was up 11% per year. Since 2017, the market jumped by 6.3% year on year to $8,140 Million. Germany, the United Kingdom and Italy respectively ranked numbers 2, 3 and 4 in this ranking.
How does Japan rank in Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins)?
| # | 18 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Japan | 2,580 | 2023 | +1.62% | +12.9% | |
| 2 | 2 Germany | 1,560 | 2023 | +2.02% | +2.23% | View data |
| 3 | 3 Canada | 533.4 | 2023 | +1.99% | +4.27% | View data |
| 4 | 4 Spain | 466.6 | 2023 | +3.57% | +0.22% | View data |
| 5 | 5 Croatia | 148.7 | 2023 | +2.2% | +0.98% | View data |
